ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2022 Annual Report
|
|
couldwellb
|
38 |
12K |
9 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
38
|
12K
|
9
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm 2022 Annual Report
|
|
couldwellb
|
38 |
12K |
9 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
38
|
12K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
0 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
0
|
|
ASX - By Stock
|
NOX |
Re:
News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study
|
|
couldwellb
|
13 |
5.1K |
4 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
13
|
5.1K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study
|
|
couldwellb
|
13 |
5.1K |
8 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
13
|
5.1K
|
8
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
42 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
42
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
couldwellb
|
21K |
7.4M |
10 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
21K
|
7.4M
|
10
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Retail Investor Briefings
|
|
couldwellb
|
50 |
23K |
0 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
50
|
23K
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
couldwellb
|
21K |
7.4M |
18 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
21K
|
7.4M
|
18
|
|
ASX - By Stock
|
NOX |
Re:
Are we expecting any news from NOX in near future?
|
|
couldwellb
|
72 |
24K |
6 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
72
|
24K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Are we expecting any news from NOX in near future?
|
|
couldwellb
|
72 |
24K |
1 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
72
|
24K
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
couldwellb
|
21K |
7.4M |
18 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
21K
|
7.4M
|
18
|
|
ASX - By Stock
|
NOX |
Re:
Ann: June 2022 Quarterly Activities Report and Appendix 4C
|
|
couldwellb
|
7 |
2.3K |
2 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
7
|
2.3K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Ann: June 2022 Quarterly Activities Report and Appendix 4C
|
|
couldwellb
|
7 |
2.3K |
1 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
7
|
2.3K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Industry related on topic
|
|
couldwellb
|
711 |
321K |
9 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
711
|
321K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Industry related on topic
|
|
couldwellb
|
711 |
321K |
11 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
711
|
321K
|
11
|
|
ASX - By Stock
|
PEC |
Re:
Ann: Completion of Priority White Sand Testing
|
|
couldwellb
|
2 |
2.4K |
1 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
2
|
2.4K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
26 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
couldwellb
|
215 |
73K |
4 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
215
|
73K
|
4
|
|
ASX - By Stock
|
NOX |
Re:
Ann: Noxopharm Corporate Presentation
|
|
couldwellb
|
18 |
10K |
3 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
18
|
10K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
RAC Primer
|
|
couldwellb
|
521 |
196K |
28 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
521
|
196K
|
28
|
|
ASX - By Stock
|
NOX |
Re:
ASCO thoughts
|
|
couldwellb
|
11 |
4.2K |
0 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
11
|
4.2K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene AML trial in Israel advances to Phase 2
|
|
couldwellb
|
233 |
83K |
16 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
233
|
83K
|
16
|
|
ASX - By Stock
|
NOX |
Re:
Ann: First Patient Treated in CEP-2 Sarcoma Trial
|
|
couldwellb
|
6 |
4.2K |
6 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
6
|
4.2K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
couldwellb
|
11K |
3.8M |
20 |
16/05/22 |
16/05/22 |
General
|
11K
|
3.8M
|
20
|
|
ASX - By Stock
|
WBT |
Re:
Industry related on topic
|
|
couldwellb
|
711 |
321K |
1 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
711
|
321K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
couldwellb
|
1.8K |
636K |
9 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
1.8K
|
636K
|
9
|
|
ASX - By Stock
|
NOX |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
couldwellb
|
74 |
25K |
2 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
74
|
25K
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q3 FY22 Activities Report and Appendix 4C
|
|
couldwellb
|
46 |
21K |
6 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
46
|
21K
|
6
|
|
ASX - By Stock
|
NOX |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
couldwellb
|
74 |
25K |
0 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
74
|
25K
|
0
|
|
ASX - By Stock
|
NOX |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
couldwellb
|
74 |
25K |
1 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
74
|
25K
|
1
|
|
ASX - By Stock
|
NOX |
Re:
Ann: March 2022 Quarterly Activities Report and Appendix 4C
|
|
couldwellb
|
74 |
25K |
9 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
74
|
25K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Industry related on topic
|
|
couldwellb
|
711 |
321K |
6 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
711
|
321K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
couldwellb
|
47 |
19K |
9 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
47
|
19K
|
9
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
23 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
23
|
|
ASX - By Stock
|
NOX |
Re:
Lutetium-177 PSMA, or LuPSMA
|
|
couldwellb
|
12 |
7.3K |
2 |
13/04/22 |
13/04/22 |
ASX - By Stock
|
12
|
7.3K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: CEO & CSO Employment Update
|
|
couldwellb
|
35 |
12K |
8 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
35
|
12K
|
8
|
|
ASX - By Stock
|
WBT |
Re:
Industry related on topic
|
|
couldwellb
|
711 |
321K |
4 |
09/04/22 |
09/04/22 |
ASX - By Stock
|
711
|
321K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
14 |
03/04/22 |
03/04/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
14
|
|
ASX - By Stock
|
WBT |
Re:
SkyWater Technology (NASDAQ: SKYT)
|
|
couldwellb
|
190 |
122K |
20 |
02/04/22 |
02/04/22 |
ASX - By Stock
|
190
|
122K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Preclinical & Clinical Programs Update
|
|
couldwellb
|
26 |
10K |
15 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
26
|
10K
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
5 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
couldwellb
|
2.9K |
1.0M |
5 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
couldwellb
|
2.9K |
1.0M |
28 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
28
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
couldwellb
|
2.9K |
1.3M |
21 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
couldwellb
|
2.9K |
1.0M |
27 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
2.9K
|
1.0M
|
27
|
|
ASX - By Stock
|
NOX |
Re:
NOX CEO Interview on Orphan Drug Status
|
|
couldwellb
|
12 |
6.5K |
2 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
12
|
6.5K
|
2
|
|
ASX - By Stock
|
NOX |
Re:
Pharmorage
|
|
couldwellb
|
15 |
6.6K |
3 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
15
|
6.6K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
FDA orphan designation for idronoxil
|
|
couldwellb
|
9 |
2.6K |
3 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
9
|
2.6K
|
3
|
|
ASX - By Stock
|
NOX |
Re:
FDA orphan designation for idronoxil
|
|
couldwellb
|
9 |
2.6K |
2 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
9
|
2.6K
|
2
|
|